Skip to content

A study on the correlation between changes in plasma and cerebrospinal fluid tryptophan canine uric acid metabolic pathway and postpartum depression

A study on the correlation between changes in plasma and cerebrospinal fluid tryptophan canine uric acid metabolic pathway and postpartum depression

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400084073
Enrollment
Unknown
Registered
2024-05-10
Start date
2024-05-20
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postpartum depression

Interventions

Sponsors

Department of Anesthesiology, Xiangya Third Hospital, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Spinal anesthesia/combined spinal epidural anesthesia for cesarean section women; 2) = 18 years old; 3) Meets the American Society of Anesthesiologists (ASA) physical condition classification II-III risk assessment criteria; 4) The patient fully understands the purpose and requirements of the trial, is able to communicate well with the follow-up, agrees to participate in this trial, and voluntarily signs an informed consent form.

Exclusion criteria

Exclusion criteria: 1) Unable to understand the language ability of the follow-up patient and communicate effectively; 2) Having unstable mental or depressive disorders; 3) Have a history of abuse of psychotropic drugs and alcohol; 4) Long term use of antidepressants within the first 6 months of the study; 5) Participate in other clinical drug trials; 6) Taboos for spinal anesthesia/combined spinal epidural anesthesia, requiring general anesthesia or natural delivery; 7) During the study, antidepressants were used through any route of administration; 8) The researchers believe that mothers with any other factors that may affect the trial results, increase maternal risk, etc. are not suitable to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
kynurenine;Quinolinic acid;kynurenic acid;Quinolinic acid phosphoribosyltransferase;

Secondary

MeasureTime frame
Tryptophan;3-Hydroxy-kynurenine;Pyridinic acid;

Countries

Chian

Contacts

Public ContactWang Saiying,Duan Kaiming

Department of Anesthesiology, Xiangya Third Hospital, Central South University

1771303488@qq.com+86 158 7485 8486

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026